164 related articles for article (PubMed ID: 32173772)
1. Resistin hormone in diabetic kidney disease and its relation to iron status and hepcidin.
Hayder ZS; Kareem ZS
Int Urol Nephrol; 2020 Apr; 52(4):749-756. PubMed ID: 32173772
[TBL] [Abstract][Full Text] [Related]
2. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
3. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
Valenti L; Girelli D; Valenti GF; Castagna A; Como G; Campostrini N; Rametta R; Dongiovanni P; Messa P; Fargion S
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1331-7. PubMed ID: 19541813
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
[No Abstract] [Full Text] [Related]
5. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum levels of hepcidin and pro-hepcidin in hemodialysis patients and healthy subjects.
Taheri N; ; Mojerloo M; Hadad M; Mirkarimi H; Nejad RK; Joshaghani HR
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):34-8. PubMed ID: 25579713
[TBL] [Abstract][Full Text] [Related]
7. Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients.
Sany D; Elsawy AE; Elshahawy Y
Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):967-73. PubMed ID: 25193892
[TBL] [Abstract][Full Text] [Related]
8. Associations of Common Variants in
Dopsaj V; Topić A; Savković M; Milinković N; Novaković I; Ćujić D; Simić-Ogrizović S
Dis Markers; 2019; 2019():4864370. PubMed ID: 30984307
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.
Takasawa K; Takaeda C; Maeda T; Ueda N
Nutrients; 2014 Dec; 7(1):103-18. PubMed ID: 25551249
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
Goyal KK; Saha A; Sahi PK; Kaur M; Dubey NK; Goyal P; Upadhayay AD
Clin Nephrol; 2018 May; 89(5):363-370. PubMed ID: 29451472
[TBL] [Abstract][Full Text] [Related]
11. Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.
Xu Y; Ding XQ; Zou JZ; Liu ZH; Jiang SH; Chen YM
J Int Med Res; 2011; 39(5):1961-7. PubMed ID: 22118000
[TBL] [Abstract][Full Text] [Related]
12. Serum Hepcidin Level as a Marker of Iron Status in Children with Cystic Fibrosis.
Kałużna-Czyż M; Grzybowska-Chlebowczyk U; Woś H; Więcek S
Mediators Inflamm; 2018; 2018():3040346. PubMed ID: 30057485
[TBL] [Abstract][Full Text] [Related]
13. The Growth Attainment, Hematological, Iron Status and Inflammatory Profile of Guatemalan Juvenile End-Stage Renal Disease Patients.
Casimiro de Almeida J; Lou-Meda R; Olbert M; Seifert M; Weiss G; Wiegerinck ET; Swinkels DW; Solomons NW; Schümann K
PLoS One; 2015; 10(10):e0140062. PubMed ID: 26445018
[TBL] [Abstract][Full Text] [Related]
14. Plasma Ferritin and Hepcidin Are Lower at 4 Months Postpartum among Women with Elevated C-Reactive Protein or α1-Acid Glycoprotein.
Jorgensen JM; Yang Z; Lönnerdal B; Chantry CJ; Dewey KG
J Nutr; 2017 Jun; 147(6):1194-1199. PubMed ID: 28446628
[No Abstract] [Full Text] [Related]
15. Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients.
Yamamoto M; Matsumoto T; Ohmori H; Takemoto M; Ikeda M; Sumimoto R; Kobayashi T; Kato A; Ohdan H
BMC Nephrol; 2021 Jun; 22(1):221. PubMed ID: 34126941
[TBL] [Abstract][Full Text] [Related]
16. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
Ueda N; Takasawa K
Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
[TBL] [Abstract][Full Text] [Related]
17. Association of Hepcidin With Anemia Parameters in Incident Dialysis Patients: Differences Between Dialysis Modalities.
Lim JH; Park YW; Lee SH; Do JY; Kim SH; Han S; Jung HY; Choi JY; Cho JH; Kim CD; Park SH; Kim YL
Ther Apher Dial; 2020 Feb; 24(1):4-16. PubMed ID: 31090188
[TBL] [Abstract][Full Text] [Related]
18. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation.
Xue D; He X; Zhou C
Transplant Proc; 2014; 46(1):156-9. PubMed ID: 24507043
[TBL] [Abstract][Full Text] [Related]
19. HEPCIDIN AND IRON BIOMARKERS MODULATED IN HEMODIALYSIS PATIENTS.
Mohammed M; Sarhat E; Marbut M
Georgian Med News; 2023 Nov; (344):101-105. PubMed ID: 38236107
[TBL] [Abstract][Full Text] [Related]
20. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
